MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$0.45
-0.04 (-8.51%)
As of Jun 30, 10:46 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,567.0% upside
Low Target $4.65
Average Target $7.44
High Target $8.88
Current Price $0.45
Current
$0.45
Target
$7.44
$4.65 $7.44 avg $8.88
Scenario Analysis
Bear Case
$4.65
941.9%
Low target
Base Case
$7.44
+1,567.0%
Avg target
Bull Case
$8.88
+1,889.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.69
-87.9% from high
52-Week Low
$0.25
+78.5% from low
Target vs 52W High
$7.44
+101.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%